What is Zometa?
Zometa, which has the generic name zoledronic acid, is prescribed to patients suffering from multiple myeloma, hypercalcemia, and some types of bone metastases. Zometa is marketed by Novartis. The drug belongs to a class known as bisphosphonates, which also includes medications such as Aredia, Actonel, and Fosamax. Bisphosphonates are designed to inhibit bone breakdown and treat debilitating bones diseases such as Paget’s disease and osteoporosis. Both Aredia and Zometa are intravenous bisphosphonates, while Actonel and Fosamax are normally taken in pill form. Zometa received its approval from the FDA in 2001. Contact us regarding Zometa; attorney consultations are free.